1.
PCN32 COMPARING FORECASTED WITH ACTUAL BUDGET IMPACT: REIMBURSED CANCER DRUGS IN THE NETHERLANDS
2.
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies